{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:01:02Z","timestamp":1785308462758,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Heart transplantation remains the definitive therapy of end-stage heart failure. Ischemia-reperfusion injury occurring during transplantation is a primary determinant of long-term outcome of heart transplantation and primary graft insufficiency. Modification of the nitric oxide\/soluble guanylate cyclase\/cyclic guanosine monophosphate signaling pathway appears to be one of the most promising among the pharmacological interventional options. We aimed at characterizing the cardio-protective effects of the soluble guanylate cyclase stimulator riociguat in a rat model of heterotopic heart transplantation. Donor Lewis rats were treated orally with either riociguat or placebo for two days (n\u2009=\u20099) in each transplanted group and (n\u2009=\u20097) in donor groups. Following explantation, hearts were heterotopically transplanted. After one hour reperfusion, left ventricular pressure-volume relations and coronary blood flow were recorded. Molecular biological measurements and histological examination were also completed. Left ventricular contractility (systolic pressure: 117\u2009\u00b1\u200913 vs. 48\u2009\u00b1\u20095\u2009mmHg, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001; dP\/dt<jats:sub>max<\/jats:sub>: 2963\u2009\u00b1\u2009221 vs. 1653\u2009\u00b1\u2009159\u2009mmHg\/s, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), active relaxation (dP\/dt<jats:sub>min<\/jats:sub>: \u22122014\u2009\u00b1\u2009305 vs. \u22121063\u2009\u00b1\u2009177\u2009mmHg\/s, <jats:italic>p<\/jats:italic>\u2009=\u20090.02; all at 120\u2009\u00b5l of left ventricular volume), and alteration of coronary blood flow standardized to heart weight (2.55\u2009\u00b1\u20090.32 vs. 1.67\u2009\u00b1\u20090.22\u2009ml\/min\/g, <jats:italic>p<\/jats:italic>\u2009=\u20090.03) were markedly increased following preconditioning with riociguat. Myocardial apoptosis markers were also significantly reduced in the riociguat pretreated group as well as the antioxidant markers were elevated. Pharmacological preconditioning with riociguat decreases ischemia-reperfusion injury and improves donor organ function in our animal model of heart transplantation. Therefore, riociguat might be a potential cardioprotective agent.<\/jats:p>","DOI":"10.1038\/s41598-020-62156-y","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T11:06:27Z","timestamp":1585047987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Stimulation of soluble guanylate cyclase improves donor organ function in rat heart transplantation"],"prefix":"10.1038","volume":"10","author":[{"given":"K\u00e1lm\u00e1n","family":"Benke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7202-8107","authenticated-orcid":false,"given":"Bal\u00e1zs Tam\u00e1s","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Ali","family":"Sayour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kl\u00e1ra Aliz","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Ol\u00e1h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mih\u00e1ly","family":"Ruppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevil","family":"Korkmaz-Ic\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter M\u00e1ria","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Benk\u0151","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Harty\u00e1nszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szabolcs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Merkely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Radovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"62156_CR1","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/TP.0000000000000620","volume":"99","author":"VB Dronavalli","year":"2015","unstructured":"Dronavalli, V. B., Rogers, C. A. & Banner, N. R. Primary Cardiac Allograft Dysfunction-Validation of a Clinical Definition. Transplantation 99, 1919\u20131925, https:\/\/doi.org\/10.1097\/TP.0000000000000620 (2015).","journal-title":"Transplantation"},{"key":"62156_CR2","doi-asserted-by":"publisher","first-page":"e83910","DOI":"10.1371\/journal.pone.0083910","volume":"8","author":"C Methner","year":"2013","unstructured":"Methner, C. et al. Riociguat reduces infarct size and post-infarct heart failure in mouse hearts: insights from MRI\/PET imaging. PLoS One 8, e83910, https:\/\/doi.org\/10.1371\/journal.pone.0083910 (2013).","journal-title":"PLoS One"},{"key":"62156_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S0008-6363(00)00078-X","volume":"47","author":"NS Dhalla","year":"2000","unstructured":"Dhalla, N. S., Elmoselhi, A. B., Hata, T. & Makino, N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 47, 446\u2013456 (2000).","journal-title":"Cardiovasc Res"},{"key":"62156_CR4","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1111\/bph.12959","volume":"172","author":"J Inserte","year":"2015","unstructured":"Inserte, J. & Garcia-Dorado, D. The cGMP\/PKG pathway as a common mediator of cardioprotection: translatability and mechanism. Br J Pharmacol 172, 1996\u20132009, https:\/\/doi.org\/10.1111\/bph.12959 (2015).","journal-title":"Br J Pharmacol"},{"key":"62156_CR5","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1161\/CIRCULATIONAHA.117.028723","volume":"136","author":"S Frankenreiter","year":"2017","unstructured":"Frankenreiter, S. et al. cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels. Circulation 136, 2337\u20132355, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028723 (2017).","journal-title":"Circulation"},{"key":"62156_CR6","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.109.870774","volume":"120","author":"S Korkmaz","year":"2009","unstructured":"Korkmaz, S. et al. Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury. Circulation 120, 677\u2013686, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.870774 (2009).","journal-title":"Circulation"},{"key":"62156_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/eurheartj\/ehs196","volume":"34","author":"E Erdmann","year":"2013","unstructured":"Erdmann, E. et al. Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure. Eur Heart J 34, 57\u201367, https:\/\/doi.org\/10.1093\/eurheartj\/ehs196 (2013).","journal-title":"Eur Heart J"},{"key":"62156_CR8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1093\/cvr\/cvy039","volume":"114","author":"S Frankenreiter","year":"2018","unstructured":"Frankenreiter, S. et al. Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase. Cardiovasc Res 114, 822\u2013829, https:\/\/doi.org\/10.1093\/cvr\/cvy039 (2018).","journal-title":"Cardiovasc Res"},{"key":"62156_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1183\/09031936.00039808","volume":"33","author":"F Grimminger","year":"2009","unstructured":"Grimminger, F. et al. First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension. Eur Respir J 33, 785\u2013792, https:\/\/doi.org\/10.1183\/09031936.00039808 (2009).","journal-title":"Eur Respir J"},{"key":"62156_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1161\/CIRCRESAHA.111.259242","volume":"110","author":"EJ Tsai","year":"2012","unstructured":"Tsai, E. J. et al. Pressure-overload-induced subcellular relocalization\/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation. Circ Res 110, 295\u2013303, https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.259242 (2012).","journal-title":"Circ Res"},{"key":"62156_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/cmdc.200900014","volume":"4","author":"J Mittendorf","year":"2009","unstructured":"Mittendorf, J. et al. Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension. ChemMedChem 4, 853\u2013865, https:\/\/doi.org\/10.1002\/cmdc.200900014 (2009).","journal-title":"ChemMedChem"},{"key":"62156_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijcard.2016.04.098","volume":"216","author":"K Pradhan","year":"2016","unstructured":"Pradhan, K. et al. Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice. Int J Cardiol 216, 85\u201391, https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.098 (2016).","journal-title":"Int J Cardiol"},{"key":"62156_CR13","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.113.001458","volume":"128","author":"D Bonderman","year":"2013","unstructured":"Bonderman, D. et al. Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study. Circulation 128, 502\u2013511, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.001458 (2013).","journal-title":"Circulation"},{"key":"62156_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14587-3","volume":"7","author":"K Benke","year":"2017","unstructured":"Benke, K. et al. Pharmacological preconditioning with gemfibrozil preserves cardiac function after heart transplantation. Sci Rep 7, 14232, https:\/\/doi.org\/10.1038\/s41598-017-14587-3 (2017).","journal-title":"Sci Rep"},{"key":"62156_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0022-5223(19)42744-X","volume":"57","author":"K Ono","year":"1969","unstructured":"Ono, K. & Lindsey, E. S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 57, 225\u2013229 (1969).","journal-title":"J Thorac Cardiovasc Surg"},{"key":"62156_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/TP.0000000000001585","volume":"101","author":"K Benke","year":"2017","unstructured":"Benke, K. et al. Heterotopic Abdominal Rat Heart Transplantation as a Model to Investigate Volume Dependency of Myocardial Remodeling. Transplantation 101, 498\u2013505, https:\/\/doi.org\/10.1097\/TP.0000000000001585 (2017).","journal-title":"Transplantation"},{"key":"62156_CR17","doi-asserted-by":"publisher","first-page":"H1697","DOI":"10.1152\/ajpheart.00595.2009","volume":"297","author":"JL Sartoretto","year":"2009","unstructured":"Sartoretto, J. L. et al. Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart. Am J Physiol Heart Circ Physiol 297, H1697\u20131710, https:\/\/doi.org\/10.1152\/ajpheart.00595.2009 (2009).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"62156_CR18","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1161\/CIRCULATIONAHA.107.670588","volume":"115","author":"BN Finck","year":"2007","unstructured":"Finck, B. N. & Kelly, D. P. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation 115, 2540\u20132548, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.670588 (2007).","journal-title":"Circulation"},{"key":"62156_CR19","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1089\/ars.2009.2940","volume":"13","author":"Z Lu","year":"2010","unstructured":"Lu, Z. et al. PGC-1 alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload. Antioxid Redox Signal 13, 1011\u20131022, https:\/\/doi.org\/10.1089\/ars.2009.2940 (2010).","journal-title":"Antioxid Redox Signal"},{"key":"62156_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1152\/advan.00052.2006","volume":"30","author":"H Liang","year":"2006","unstructured":"Liang, H. & Ward, W. F. PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ 30, 145\u2013151, https:\/\/doi.org\/10.1152\/advan.00052.2006 (2006).","journal-title":"Adv Physiol Educ"},{"key":"62156_CR21","doi-asserted-by":"publisher","first-page":"10086","DOI":"10.1073\/pnas.0603615103","volume":"103","author":"Z Arany","year":"2006","unstructured":"Arany, Z. et al. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc Natl Acad Sci USA 103, 10086\u201310091, https:\/\/doi.org\/10.1073\/pnas.0603615103 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"62156_CR22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.cardiores.2005.01.026","volume":"66","author":"I Valle","year":"2005","unstructured":"Valle, I., Alvarez-Barrientos, A., Arza, E., Lamas, S. & Monsalve, M. PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc Res 66, 562\u2013573, https:\/\/doi.org\/10.1016\/j.cardiores.2005.01.026 (2005).","journal-title":"Cardiovasc Res"},{"key":"62156_CR23","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1089\/ars.2012.4615","volume":"18","author":"K Aquilano","year":"2013","unstructured":"Aquilano, K. et al. p53 orchestrates the PGC-1alpha-mediated antioxidant response upon mild redox and metabolic imbalance. Antioxid Redox Signal 18, 386\u2013399, https:\/\/doi.org\/10.1089\/ars.2012.4615 (2013).","journal-title":"Antioxid Redox Signal"},{"key":"62156_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.theriogenology.2018.12.007","volume":"126","author":"YX Guo","year":"2019","unstructured":"Guo, Y. X. et al. Effects of nitric oxide on steroidogenesis and apoptosis in goat luteinized granulosa cells. Theriogenology 126, 55\u201362, https:\/\/doi.org\/10.1016\/j.theriogenology.2018.12.007 (2019).","journal-title":"Theriogenology"},{"key":"62156_CR25","doi-asserted-by":"publisher","first-page":"e98459","DOI":"10.1371\/journal.pone.0098459","volume":"9","author":"TJ Kalogeris","year":"2014","unstructured":"Kalogeris, T. J., Baines, C. & Korthuis, R. J. Adenosine prevents TNFalpha-induced decrease in endothelial mitochondrial mass via activation of eNOS-PGC-1alpha regulatory axis. PLoS One 9, e98459, https:\/\/doi.org\/10.1371\/journal.pone.0098459 (2014).","journal-title":"PLoS One"},{"key":"62156_CR26","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1096\/fj.05-5189fje","volume":"20","author":"S Borniquel","year":"2006","unstructured":"Borniquel, S., Valle, I., Cadenas, S., Lamas, S. & Monsalve, M. Nitric oxide regulates mitochondrial oxidative stress protection via the transcriptional coactivator PGC-1alpha. FASEB J 20, 1889\u20131891, https:\/\/doi.org\/10.1096\/fj.05-5189fje (2006).","journal-title":"FASEB J"},{"key":"62156_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.niox.2018.03.013","volume":"76","author":"RC Shah","year":"2018","unstructured":"Shah, R. C., Sanker, S., Wood, K. C., Durgin, B. G. & Straub, A. C. Redox regulation of soluble guanylyl cyclase. Nitric Oxide 76, 97\u2013104, https:\/\/doi.org\/10.1016\/j.niox.2018.03.013 (2018).","journal-title":"Nitric Oxide"},{"key":"62156_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jacc.2010.08.628","volume":"57","author":"M Agosto","year":"2011","unstructured":"Agosto, M., Azrin, M., Singh, K., Jaffe, A. S. & Liang, B. T. Serum caspase-3 p17 fragment is elevated in patients with ST-segment elevation myocardial infarction: a novel observation. J Am Coll Cardiol 57, 220\u2013221, https:\/\/doi.org\/10.1016\/j.jacc.2010.08.628 (2011).","journal-title":"J Am Coll Cardiol"},{"key":"62156_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrcardio.2016.5","volume":"13","author":"DJ Hausenloy","year":"2016","unstructured":"Hausenloy, D. J. & Yellon, D. M. Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol 13, 193\u2013209, https:\/\/doi.org\/10.1038\/nrcardio.2016.5 (2016).","journal-title":"Nat Rev Cardiol"},{"key":"62156_CR30","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1160\/TH14-08-0703","volume":"112","author":"HA Cabrera-Fuentes","year":"2014","unstructured":"Cabrera-Fuentes, H. A. et al. RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-alpha in cardiac ischaemia\/reperfusion injury. Thromb Haemost 112, 1110\u20131119, https:\/\/doi.org\/10.1160\/TH14-08-0703 (2014).","journal-title":"Thromb Haemost"},{"key":"62156_CR31","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1083\/jcb.101.3.880","volume":"101","author":"PE Stenberg","year":"1985","unstructured":"Stenberg, P. E., McEver, R. P., Shuman, M. A., Jacques, Y. V. & Bainton, D. F. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 101, 880\u2013886, https:\/\/doi.org\/10.1083\/jcb.101.3.880 (1985).","journal-title":"J Cell Biol"},{"key":"62156_CR32","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1073\/pnas.0304264101","volume":"101","author":"A Ahluwalia","year":"2004","unstructured":"Ahluwalia, A. et al. Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment. Proc Natl Acad Sci USA 101, 1386\u20131391, https:\/\/doi.org\/10.1073\/pnas.0304264101 (2004).","journal-title":"Proc Natl Acad Sci USA"},{"key":"62156_CR33","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1182\/blood.V82.4.1308.1308","volume":"82","author":"M Dore","year":"1993","unstructured":"Dore, M., Korthuis, R. J., Granger, D. N., Entman, M. L. & Smith, C. W. P-selectin mediates spontaneous leukocyte rolling in vivo. Blood 82, 1308\u20131316 (1993).","journal-title":"Blood"},{"key":"62156_CR34","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.healun.2015.05.006","volume":"34","author":"S Loganathan","year":"2015","unstructured":"Loganathan, S. et al. Effects of soluble guanylate cyclase activation on heart transplantation in a rat model. J Heart Lung Transplant 34, 1346\u20131353, https:\/\/doi.org\/10.1016\/j.healun.2015.05.006 (2015).","journal-title":"J Heart Lung Transplant"},{"key":"62156_CR35","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/ejcts\/ezw426","volume":"51","author":"S Korkmaz-Icoz","year":"2017","unstructured":"Korkmaz-Icoz, S. et al. Prolonging hypothermic ischaemic cardiac and vascular storage by inhibiting the activation of the nuclear enzyme poly(adenosine diphosphate-ribose) polymerase. Eur J Cardiothorac Surg 51, 829\u2013835, https:\/\/doi.org\/10.1093\/ejcts\/ezw426 (2017).","journal-title":"Eur J Cardiothorac Surg"},{"key":"62156_CR36","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1111\/ajt.14207","volume":"17","author":"S Li","year":"2017","unstructured":"Li, S. et al. Donor Preconditioning After the Onset of Brain Death With Dopamine Derivate n-Octanoyl Dopamine Improves Early Posttransplant Graft Function in the Rat. Am J Transplant 17, 1802\u20131812, https:\/\/doi.org\/10.1111\/ajt.14207 (2017).","journal-title":"Am J Transplant"},{"key":"62156_CR37","doi-asserted-by":"publisher","first-page":"e49237","DOI":"10.1371\/journal.pone.0049237","volume":"7","author":"S Li","year":"2012","unstructured":"Li, S. et al. Acute ethanol exposure increases the susceptibility of the donor hearts to ischemia\/reperfusion injury after transplantation in rats. PLoS One 7, e49237, https:\/\/doi.org\/10.1371\/journal.pone.0049237 (2012).","journal-title":"PLoS One"},{"key":"62156_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jss.2014.12.038","volume":"195","author":"S Li","year":"2015","unstructured":"Li, S. et al. Transplantation of donor hearts after circulatory or brain death in a rat model. J Surg Res 195, 315\u2013324, https:\/\/doi.org\/10.1016\/j.jss.2014.12.038 (2015).","journal-title":"J Surg Res"},{"key":"62156_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep37166","volume":"6","author":"BT Nemeth","year":"2016","unstructured":"Nemeth, B. T. et al. Cinaciguat prevents the development of pathologic hypertrophy in a rat model of left ventricular pressure overload. Sci Rep 6, 37166, https:\/\/doi.org\/10.1038\/srep37166 (2016).","journal-title":"Sci Rep"},{"key":"62156_CR40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12933-015-0309-x","volume":"14","author":"C Matyas","year":"2015","unstructured":"Matyas, C. et al. The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus. Cardiovasc Diabetol 14, 145, https:\/\/doi.org\/10.1186\/s12933-015-0309-x (2015).","journal-title":"Cardiovasc Diabetol"},{"key":"62156_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12933-017-0645-0","volume":"17","author":"C Matyas","year":"2018","unstructured":"Matyas, C. et al. Comparison of speckle-tracking echocardiography with invasive hemodynamics for the detection of characteristic cardiac dysfunction in type-1 and type-2 diabetic rat models. Cardiovasc Diabetol 17, 13, https:\/\/doi.org\/10.1186\/s12933-017-0645-0 (2018).","journal-title":"Cardiovasc Diabetol"},{"key":"62156_CR42","doi-asserted-by":"publisher","first-page":"H692","DOI":"10.1152\/ajpheart.00634.2005","volume":"290","author":"Y Xu","year":"2006","unstructured":"Xu, Y. et al. Activated platelets contribute importantly to myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 290, H692\u2013699, https:\/\/doi.org\/10.1152\/ajpheart.00634.2005 (2006).","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62156-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62156-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62156-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:50:08Z","timestamp":1670316608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62156-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["62156"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-62156-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]},"assertion":[{"value":"9 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5358"}}